{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:39:06Z","timestamp":1792791546029,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015763","name":"University of Szeged","doi-asserted-by":"publisher","award":["8592"],"award-info":[{"award-number":["8592"]}],"id":[{"id":"10.13039\/501100015763","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003827","name":"National Research Development and Innovation Office","doi-asserted-by":"publisher","award":["EK\\u00D6P-321"],"award-info":[{"award-number":["EK\\u00D6P-321"]}],"id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012550","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innovaci\u00f3s Alap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012550","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neuropharm.2026.111190","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:32:36Z","timestamp":1789572756000},"page":"111190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Behavioral and molecular effects of \u03b12A-adrenergic receptor activation in the triple-hit Lisket rat model of schizophrenia"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6025-4577","authenticated-orcid":false,"given":"Gyongyi","family":"Horvath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szonja Bianka","family":"Plesz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5219-8491","authenticated-orcid":false,"given":"Eszter","family":"Ducza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Szatm\u00e1ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0807-6630","authenticated-orcid":false,"given":"Emese","family":"Solymos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor","family":"Ny\u00e1ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0185-2155","authenticated-orcid":false,"given":"Gabriella","family":"Kekesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111190_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12031-011-9539-x","article-title":"Changes in the mRNA levels of \u03b12A and \u03b12C adrenergic receptors in rat models of Parkinson's disease and L-DOPA-induced dyskinesia","volume":"46","author":"Alachkar","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111190_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.nlm.2020.107327","article-title":"Guanfacine's mechanism of action in treating prefrontal cortical disorders: successful translation across species","volume":"176","author":"Arnsten","year":"2020","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2026.111190_bib4","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1038\/s41380-023-02057-4","article-title":"Scientific rationale for the use of \u03b12A-adrenoceptor agonists in treating neuroinflammatory cognitive disorders","volume":"28","author":"Arnsten","year":"2023","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.111190_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.neuro.28.061604.135709","article-title":"An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance","volume":"28","author":"Aston-Jones","year":"2005","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111190_bib6","series-title":"Norepinephrine: Clinical Aspects","first-page":"92","article-title":"Anatomy and physiology of locus coeruleus neurons","author":"Aston-Jones","year":"1984"},{"key":"10.1016\/j.neuropharm.2026.111190_bib7","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1038\/sj.npp.1301580","article-title":"The effects of clonidine on discrete-trial delayed spatial alternation in two rat models of memory loss","volume":"33","author":"Bardgett","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111190_bib8","article-title":"Enhancement of function of the prefrontal cortex to improve symptoms of schizophrenia","author":"Bardoloi","year":"2020","journal-title":"Acta Scient Neurol"},{"key":"10.1016\/j.neuropharm.2026.111190_bib9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1152\/jn.00943.2007","article-title":"Alpha2-adrenergic receptors modify dendritic spike generation via HCN channels in the prefrontal cortex","volume":"99","author":"Barth","year":"2008","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2026.111190_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.euroneuro.2021.05.012","article-title":"\u03b12A- and \u03b12C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects","volume":"52","author":"Brocos-Mosquera","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111190_bib13","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/pcn.13892","article-title":"Repurposed antihypertensive drugs for negative symptoms in schizophrenia: a systematic review and meta-analysis","volume":"79","author":"Carnaval","year":"2025","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111190_bib14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuroscience.2016.06.037","article-title":"\u03b12A adrenergic receptors highly expressed in mesoprefrontal dopamine neurons","volume":"332","author":"Castelli","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.111190_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2026.111190_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141327","article-title":"A comparison of the anorectic effect and safety of the Alpha2-Adrenoceptor ligands guanfacine and yohimbine in rats with diet-induced obesity","volume":"10","author":"Dudek","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.111190_bib17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0306-4530(01)00094-4","article-title":"Effects of testosterone on alpha2A-adrenergic receptor expression in the rat brain","volume":"27","author":"Dygalo","year":"2002","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2026.111190_bib18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00213-006-0558-1","article-title":"Guanfacine produces differential effects in frontal cortex compared with striatum: assessed by phMRI BOLD contrast","volume":"189","author":"Easton","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.111190_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0920-9964(88)90024-2","article-title":"Clonidine improves memory function in schizophrenia independently from change in psychosis. Preliminary findings","volume":"1","author":"Fields","year":"1988","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2026.111190_bib20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0893-133X(01)00249-4","article-title":"Guanfacine treatment of cognitive impairment in schizophrenia","volume":"25","author":"Friedman","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111190_bib21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2007.10.007","article-title":"Effects of chronic desipramine treatment on alpha2-adrenoceptors and mu-opioid receptors in the guinea pig cortex and hippocampus","volume":"579","author":"Giaroni","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111190_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1476-5381.2011.01533.x","article-title":"Are the pharmacology and physiology of \u03b12 adrenoceptors determined by \u03b12-heteroreceptors and autoreceptors respectively?","volume":"165","author":"Gilsbach","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111190_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.31887\/DCNS.2019.21.2\/vhede","article-title":"Treating psychiatric symptoms and disorders with non-psychotropic medications","volume":"21","author":"Hede","year":"2019","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111190_bib24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00441-006-0285-2","article-title":"Adrenoceptors and signal transduction in neurons","volume":"326","author":"Hein","year":"2006","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuropharm.2026.111190_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2026.105051","article-title":"Transgenerational consolidation of schizophrenia-relevant behavioral phenotypes reveals sex-specific trajectories and individual heterogeneity","volume":"146","author":"Horvath","year":"2026","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.neuropharm.2026.111190_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.70015","article-title":"Distinct effects of olanzapine depot treatment on behavior and muscarinic M1 receptor expression in the triple-hit wisket rat model of schizophrenia","volume":"24","author":"Horvath","year":"2025","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuropharm.2026.111190_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.physbeh.2016.11.039","article-title":"Characterization of exploratory activity and learning ability of healthy and \u201cschizophrenia-like\u201d rats in a square corridor system (AMBITUS)","volume":"169","author":"Horvath","year":"2017","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2026.111190_bib31","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.3390\/ijms26136019","article-title":"Repurposing caffeine, metformin, and furosemide to target schizophrenia-related impairments in a triple-hit rat model","volume":"26","author":"Horvath","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111190_bib32","article-title":"Investigating antidiabetic drug targets as potential therapeutic modulators for schizophrenia","author":"Huang","year":"2025","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.111190_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00213-004-1772-3","article-title":"A low dose of the alpha2 agonist clonidine ameliorates the visual attention and spatial working memory deficits produced by phencyclidine administration to rats","volume":"175","author":"Jentsch","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.111190_bib34","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1038\/sj.npp.1301603","article-title":"Stimulation of alpha2-adrenoceptors suppresses excitatory synaptic transmission in the medial prefrontal cortex of rat","volume":"33","author":"Ji","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111190_bib35","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bbr.2014.05.044","article-title":"Stimulation of postsynapse adrenergic \u03b12A receptor improves attention\/cognition performance in an animal model of attention deficit hyperactivity disorder","volume":"270","author":"Kawaura","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2026.111190_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0893-133X(98)00134-1","article-title":"Brain noradrenergic receptors in major depression and schizophrenia","volume":"21","author":"Klimek","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111190_bib38","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41597-026-06735-0","article-title":"Behavioral dataset for Long-Evans and its schizophrenia-like substrain through several generations","volume":"13","author":"K\u0151r\u00f6si","year":"2026","journal-title":"Sci. Data"},{"key":"10.1016\/j.neuropharm.2026.111190_bib39","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/bja\/83.6.945","article-title":"Inhibitory effect of clonidine on ketamine-induced norepinephrine release from the medial prefrontal cortex in rats","volume":"83","author":"Kubota","year":"1999","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2026.111190_bib40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/biom13050843","article-title":"Distribution of \u03b12-Adrenergic receptors in the living human brain using [11C]yohimbine PET","volume":"13","author":"Laurencin","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuropharm.2026.111190_bib41","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1192\/bjp.168.5.571","article-title":"Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine","volume":"168","author":"Litman","year":"1996","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111190_bib42","doi-asserted-by":"crossref","first-page":"13233","DOI":"10.1074\/jbc.M807535200","article-title":"Epitope-tagged receptor knock-in mice reveal that differential desensitization of alpha2-adrenergic responses is because of ligand-selective internalization","volume":"284","author":"Lu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.111190_bib43","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neubiorev.2020.07.038","article-title":"The role of norepinephrine in the pathophysiology of schizophrenia","volume":"118","author":"M\u00e4ki-Marttunen","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2026.111190_bib44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fpsyt.2017.00042","article-title":"The role of norepinephrine and its \u03b1-Adrenergic receptors in the pathophysiology and treatment of major depressive disorder and schizophrenia: a systematic review","volume":"8","author":"Maletic","year":"2017","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.111190_bib45","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/sj.npp.1300700","article-title":"Alpha-2 adrenoceptor activation inhibits phencyclidine-induced deficits of spatial working memory in rats","volume":"30","author":"Marrs","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111190_bib46","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0301-0082(81)90016-2","article-title":"Noradrenaline in the brain: progress in theories of behavioural function","volume":"16","author":"Mason","year":"1981","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111190_bib47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1176\/appi.ajp.2018.18030349","article-title":"Guanfacine augmentation of a combined intervention of computerized cognitive remediation therapy and social skills training for schizotypal personality disorder","volume":"176","author":"McClure","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111190_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/npp.1994.6","article-title":"Electrophysiologic evidence for desensitization of alpha 2-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration","volume":"10","author":"Mongeau","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111190_bib49","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00213-005-0078-4","article-title":"Lack of effects of guanfacine on executive and memory functions in healthy male volunteers","volume":"182","author":"M\u00fcller","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.111190_bib50","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/neurolint15020043","article-title":"The role of Alpha-2 agonists for attention deficit hyperactivity disorder in children: a review","volume":"15","author":"Neuchat","year":"2023","journal-title":"Neurol. Int."},{"key":"10.1016\/j.neuropharm.2026.111190_bib52","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.2174\/1570159X21666230221093644","article-title":"Neurobehavioral profiles of six genetically-based rat models of Schizophrenia- related symptoms","volume":"21","author":"Oliveras","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2026.111190_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105526","article-title":"The 3-hit animal models of schizophrenia: improving strategy to decipher and treat the disease?","volume":"157","author":"Percelay","year":"2024","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2026.111190_bib54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.nlm.2006.08.005","article-title":"To press or not to press? Differential receptor expression and response to novelty in rats learning an operant response for reward","volume":"87","author":"Pickering","year":"2007","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2026.111190_bib55","doi-asserted-by":"crossref","DOI":"10.1111\/ejn.70111","article-title":"The locus coeruleus: anatomy, physiology, and stress-related neuropsychiatric disorders","volume":"61","author":"Reyes","year":"2025","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111190_bib56","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/02698811030173010","article-title":"Caffeine and central noradrenaline: effects on mood, cognitive performance, eye movements and cardiovascular function","volume":"17","author":"Smith","year":"2003","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111190_bib57","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1038\/s41380-023-02138-4","article-title":"Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019","volume":"28","author":"Solmi","year":"2023","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.111190_bib58","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.pnpbp.2003.09.009","article-title":"Alpha-adrenoceptor modulation hypothesis of antipsychotic atypicality","volume":"27","author":"Svensson","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111190_bib59","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/(SICI)1096-9861(19960812)372:1<111::AID-CNE8>3.0.CO;2-6","article-title":"Distribution of alpha 2A-adrenergic receptor-like immunoreactivity in the rat central nervous system","volume":"372","author":"Talley","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111190_bib60","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/0269881105051529","article-title":"Selective effects of clonidine and temazepam on attention and memory","volume":"19","author":"Tiplady","year":"2005","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111190_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106233","article-title":"The role of the LC-NE system in attention: from cells, to systems, to sensory-motor control","volume":"175","author":"Torres","year":"2025","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2026.111190_bib62","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.106362","article-title":"Chronic stress impairs autoinhibition in neurons of the locus coeruleus to increase asparagine endopeptidase activity","volume":"14","author":"Toyoda","year":"2025","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2026.111190_bib63","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0920-9964(91)90032-M","article-title":"Dopamine and norepinephrine activity in schizophrenia. An integrative perspective","volume":"4","author":"van Kammen","year":"1991","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2026.111190_bib64","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0031-6997(24)01436-4","article-title":"Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system","volume":"52","author":"Vizi","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2026.111190_bib65","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/biomedicines11010222","article-title":"Noradrenergic modulation of learned and innate behaviors in dopamine transporter knockout rats by guanfacine","volume":"11","author":"Volnova","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuropharm.2026.111190_bib66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0014-2999(94)90058-2","article-title":"Pharmacological characterization of [3H]idazoxan,[3H]RX821002 and p-[125I]iodoclonidine binding to 2-adrenoceptors in rat cerebral cortical membranes","volume":"258","author":"Wallace","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111190_bib67","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0306-4522(96)00116-9","article-title":"Expression of alpha 2-adrenergic receptor subtypes in the mouse brain: evaluation of spatial and temporal information imparted by 3 kb of 5\u2019 regulatory sequence for the alpha 2A AR-receptor gene in transgenic animals","volume":"74","author":"Wang","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.111190_bib68","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1007\/s00213-020-05590-0","article-title":"Lack of) effects of noradrenergic stimulation on human working memory performance","volume":"237","author":"Wanke","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.111190_bib69","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.pnpbp.2004.05.033","article-title":"Proposal for a noradrenaline hypothesis of schizophrenia","volume":"28","author":"Yamamoto","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111190_bib70","article-title":"Chronic unpredictable stress induces depression\/anxiety-related behaviors and alterations of hippocampal monoamine receptor mRNA expression in female mice at different ages","volume":"9","author":"Zhou","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.neuropharm.2026.111190_bib71","article-title":"Behavioral characterization of triple-hit schizophrenia-like Lisket rats derived from the Long Evans strain through acute and chronic behavioral tests","volume":"16","author":"Zoldi","year":"2025","journal-title":"Front. Psychiatr."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:54:09Z","timestamp":1792788849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826003655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":63,"alternative-id":["S0028390826003655"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111190","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavioral and molecular effects of \u03b12A-adrenergic receptor activation in the triple-hit Lisket rat model of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111190"}}